EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma

Manuel J Pérez-Baena, Jian-Hua Mao, Jesús Pérez-Losada, Ángel Santos-Briz, Hang Chang, Javier Cañueto iD

Clinical and Experimental Dermatology · 25.06.2024 · 49 (7) · 692-698

DOI: 10.1093/ced/llad264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 12.08.2023. Verfasst von Manuel J Pérez-Baena und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca/CSIC, Salamanca, Spain. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Artificial Intelligence. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Cancer Institute at the National Institutes of Health, Lawrence Berkeley National Laboratory, University of California.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Risk stratification of cutaneous squamous cell carcinoma (cSCC) is essential for managing patients.

Objectives

To determine if artificial intelligence and machine learning might help to stratify patients with cSCC by risk using more than solely clinical and histopathological factors.

Methods

We retrieved a retrospective cohort of 104 patients whose cSCCs had been excised with clear margins. Clinical and histopathological risk factors were evaluated. Haematoxylin and eosin-stained slides were scanned and analysed by an algorithm based on the stacked predictive sparse decomposition technique. Cellular morphometric biomarkers (CMBs) were identified via machine learning and used to derive a cellular morphometric risk score (CMRS) that classified cSCCs into clusters of differential prognoses. Concordance analysis, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were calculated and compared with results obtained with the Brigham and Women’s Hospital (BWH) staging system. The performance of the combination of the BWH staging system and the CMBs was also analysed.

Results

There were no differences among the CMRS groups in terms of clinical and histopathological risk factors and T-stage assignment, but there were significant differences in prognosis. Combining the CMRS with BWH staging systems increased distinctiveness and improved prognostic performance. C-indices were 0.91 local recurrence and 0.91 for nodal metastasis when combining the two approaches. The NPV was 94.41% and 96.00%, the PPV was 36.36% and 41.67%, and accuracy reached 86.75% and 89.16%, respectively, with the combined approach.

Conclusions

CMRS is helpful for cSCC risk stratification beyond classic clinical and histopathological risk features. Combining the information from the CMRS and the BWH staging system offers outstanding prognostic performance for patients with high-risk cSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellArtificial IntelligenceHumansRetrospective StudiesFemalePrognosisMaleAgedMiddle AgedRisk AssessmentNeoplasm StagingRisk FactorsAged, 80 and overMachine LearningNeoplasm Recurrence, LocalAdultAlgorithmsPredictive Value of Tests

Autor:innen und Institutionen

  • Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca/CSIC, Salamanca, Spain.
  • Instituto de Investigación Biomédica de Salamanca.
  • Berkeley Biomedical Data Science Center.
  • Biological Systems and Engineering Division; Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
  • Servicio de Anatomía Patológica.
  • Servicio de Dermatología; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.

ORCID-Profile: Javier Cañueto

Förderung

  • National Cancer Institute at the National Institutes of Health
  • Lawrence Berkeley National Laboratory
  • University of California
  • Department of Energy
  • European Union Next Generation EU/PRTR
  • Regional Government of Castile and León
  • Instituto de Salud Carlos III
  • Programa de Intensificación

Zitieren

APA

Pérez-Baena, M. J., Mao, J. H., Pérez-Losada, J., Santos-Briz, Á., Chang, H., & Cañueto, J. (2024). Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma. Clinical and Experimental Dermatology, 49(7), 692-698. https://doi.org/10.1093/ced/llad264

Vancouver

Pérez-Baena MJ, Mao JH, Pérez-Losada J, Santos-Briz Á, Chang H, Cañueto J. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma. Clinical and Experimental Dermatology. 2024;49(7):692-698. doi:10.1093/ced/llad264

BibTeX
@article{PrezBaena2024,
  author = {Pérez-Baena, Manuel J and Mao, Jian-Hua and Pérez-Losada, Jesús and Santos-Briz, Ángel and Chang, Hang and Cañueto, Javier},
  title = {Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  volume = {49},
  number = {7},
  pages = {692--698},
  doi = {10.1093/ced/llad264}
}
Kostenlos starten →